Pfizer Inc.
Methyl- and trifluromethyl-substituted pyrrolopyridine modulators of RORC2 and methods of use thereof

Abstract:

The present invention provides methyl- and trifluoromethyl-substituted pyrrolopyridines, pharmaceutical compositions thereof, methods of modulating ROR.gamma. activity and/or reducing the amount of IL-17 in a subject, and methods of treating various medical disorders using such pyrrolopyridines and pharmaceutical compositions thereof.